Nutrien (NYSE:NTR) reported Q4 EPS of $2.02, $0.55 worse than the analyst estimate of $2.57. Revenue for the quarter came in at $7.53 billion versus the consensus estimate of $7.49 billion.
GUIDANCE:
Nutrien sees FY2023 EPS of $8.45-$10.65, versus the consensus of $11.49.